Antiverse collaborates with a top 20 pharma company to identify antibody drug candidates using AI Augmented Drug Discovery platform
Antiverse, a biotechnology company developing a computational antibody drug discovery platform, today announced a partnership with a top 20 pharma company with core competencies in the life science fields of health care and nutrition.
Novel tech for ‘cocktail party’ hearing problem could help over 200m people
Breakthrough technology from Cambridge audio software specialist AudioTelligence is set to help solve the ‘cocktail party problem’.
Cambridge-based Qureight raises £1.5 million to curate collection of complex disease data
Cambridge-based data company Qureight has raised £1.5 million seed funding to deliver the next generation of its ground-breaking platform and capitalise on its vision to house the world’s largest collection of data from complex diseases.
Phico Therapeutics establishes Scientific Advisory Board
Phico Therapeutics Ltd (‘Phico’), a biotechnology company developing engineered phage technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, today announced that it has established a Science Advisory Board (SAB) to provide strategic scientific guidance to the Company.
DefiniGEN appoints Dr Chris Kirton as Chief Executive Officer
DefiniGEN have announced the appointment of Dr Chris Kirton as Chief Executive Officer.
Eagle Genomics Selected for Catalonia-Based Initiative to Support Expansion into Spanish-Speaking Markets
Eagle Genomics, the Deep Tech platform business pioneering the application of network science to biology across the Food and Nutrition, Biopharma, Beauty and Personal Care, and AgBio industries, announced that it has been selected to participate in the Fast-Track Programme to Barcelona-Catalonia Life Science Hub (‘Programme’), Catalonia Trade & Investment’s initiative for UK firms looking to expand to Spanish-speaking markets.
DefiniGEN appoints Dr Chris Kirton as Chief Executive Officer
Cambridge, UK – 20th January 2022 – Life Science Newswire – DefiniGEN is pleased to announce the appointment of Dr Chris Kirton as Chief Executive Officer. Chris has more than 16 years of operational experience and joined DefiniGEN as Chief Operating Officer in June 2020.
Arecor commences US Phase I clinical trial of AT247 ultra-rapid insulin in combination with an insulin pump
First patient dosed in potential game-changing diabetes combination therapy.
Audio Analytic's Alexandria dataset now contains over half-a-billion metadata points
At the heart of Audio Analytic's Alexandria™ data platform is the Alexandria dataset, the world’s largest, commercially-exploitable dataset for audio ML tasks.
Wazoku Chosen as a 2021 Red Herring Top 100 Europe Winner
Innovation scale-up recognised as one of Europe's most outstanding tech firms
PhoreMost expands into new facility at Unity Campus, Cambridge, UK
PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets has announced it has relocated its headquarters to Unity Campus, a high-specification technology and innovation park, owned by leading regional property developers and investors, Howard Group, in south Cambridge.
With £8.5M funding, this UK medical device startup hopes to transform dialysis treatment less invasive
Currently, preparing a patient for dialysis involves a significant surgical intervention associated with risks for the patient.
Lunar switches to Thought Machine to power Nordic banking expansion
The Nordic’s “next financial powerhouse”.
Flusso gets £46,000 local grant for expansion
Cambridge fabless chip company Flusso has received “almost £46,000” from Growth Works, the development programme launched last year by the Cambridgeshire & Peterborough Combined Authority and Business Board – backed with UK government and EU funding.
ieso shortlisted for HSJ Partnership Awards 2022
ieso is delighted to announce that their joint submission in partnership with Dorset HealthCare University NHS Foundation Trust has been shortlisted for Best Mental Health Partnership With the NHS at the HSJ Partnership Awards 2022, recognising their outstanding contribution to healthcare – in what has been an exceptional and challenging period across the sector.
Bristol-based Rovco secures £2m from BOOST&Co
Bristol-based Rovco provides autonomous underwater vehicles (AUV) and remotely operated vehicles (ROV) to the offshore wind industry and has secured £2m of funding from the independent asset manager BOOST&Co.
Eagle-Quadram alliance boosts microbiome science
A new partnership committed to promoting the understanding of microbiome science has been set up by Cambridge’s Eagle Genomics and the Quadram Institute in Norwich.
NeoCura and PhoreMost Announce Research Collaboration to Explore Novel Cancer Therapeutics
NeoCura Bio-Medical Technology Co., Ltd. (“NeoCura”), a leading RNA-based drug research and development company in China, and PhoreMost Limited (PhoreMost), the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’, today announced an oncology drug discovery research collaboration.
This rare metal could soon be replaced in mobile phone screens
Researchers from Paragraf and the Queen Mary University of London have published a new study in the journal Advanced Optical Materials on the potential replacement.
Arecor due to transfer formulation for new medicine to Hikma Pharmaceuticals in first half of 2022
Arecor Therapeutics expects to transfer the final formulation for a new ready-to-use, injectable medicine to Hikma Pharmaceuticals in the first half of 2022.